CTS Corp CEO Uses 10b5‑1 Plan to Sell 130,000 Shares—What Investors Need to Know
CEO O’Sullivan’s 10b5‑1 sales at CTS Corp illustrate a disciplined, compliant insider strategy that reassures investors, preserves capital structure, and sets a governance benchmark in tech.
4 minutes to read






